Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.
  • ArrayPharmacy
  • call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.


  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • Patientforms
  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:

    • certified

      Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

      Learn More

    A New Non-Invasive Test to Detect Breast Cancer Early

    A new blood test that detects breast cancer has been discovered by researchers. The non-invasive method will be able to identify breast cancer five years before any clinical signs of the disease appear. During the test, auto-antibodies for the tumor antigens will predict breast cancer presence. Researchers have confirmed that this blood screening method will be ready for clinical use in four to five years’ time.

    Early detection of breast cancer can help both patients and doctors prevent its progression. The invention of this advanced screening method adds to the many efforts by researchers to find better ways of fighting the disease, such as the breast cancer vaccine.

    All body cells, including cancer cells, produce antigens. When these antigens are exposed to other cells within the body, they cause the immune system to generate auto-antibodies. Tumor-associated antigens indicate that cancer is present. In the same way, when an antigen’s auto-antibody appears, it means that a tumor is present.

    During the study:

    • Researchers built blood panels against the type of blood to be screened. They used a protein microarray for the antibodies linked to tumor-associated antigens in breast cancer tumors. Forty antibodies were tested, with 27 of them not related to breast cancer. Each blood panel was targeted to a subset of antibodies.
    • The blood samples were from both patients diagnosed with breast cancer and volunteers without the disease. It was observed that breast cancer could induce auto-antibodies on particular tumor-associated antigens. Cancer could be accurately be detected by identifying the autoantibodies in a patient’s blood.

    Although the outcomes of this research are promising, more research is needed to validate this test. Once this is done, early detection of breast cancer will be a cost-effective process that will benefit all patients, especially those in middle and low-income countries. These results have also sparked the interest of researchers to come up with similar methods of early detection in other cancers like lung cancer.

    Cancer Screening Guidelines

    Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

    Learn More

    Learn About Your Options

    Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

    Learn More